|
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
| 1R21DA055427-01 |
|
NIDA |
2022 |
|
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
| 1R21DA055980-01 |
|
NIDA |
2022 |
|
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
| 1R21DA056293-01 |
|
NIDA |
2022 |
|
|
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo |
| 5R01DA045596-05 |
|
NIDA |
2022 |
|
|
Exploring biomarkers of sex-based disparities in relapsing multiple sclerosis |
| 1F31NR020146-01A1 |
|
NINR |
2022 |
|
|
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial |
| 1R01NR020323-01A1 |
|
NINR |
2022 |
|
|
Informal Advance Care Planning with Family in Blacks with End Stage Renal Disease on Hemodialysis |
| 5F31NR019211-03 |
|
NINR |
2022 |
|
|
Contextual Predictors of Hospitalization and Quality of Life among Patients on Hemodialysis |
| 5F31NR019461-02 |
|
NINR |
2022 |
|
|
Preparing Patient-Caregiver Dyads with Parkinsons Disease for End-of-Life Decision Making |
| 5K23NR019099-02 |
|
NINR |
2022 |
|
|
Lipidomics in Acute Ischemic Stroke: Relationship to Symptoms and Outcomes |
| 5K23NR019864-03 |
|
NINR |
2022 |